Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page
- Check3 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, marking a new version of the page. This appears to be an administrative update rather than a change to displayed information.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new revision of the page. This is a minor metadata update signaling a refreshed version rather than a substantive content change.SummaryDifference0.1%

- Check46 days agoChange DetectedThis updates the displayed ClinicalTrials.gov page revision/version from v3.5.2 to v3.5.3, indicating a site version refresh rather than any change to the underlying study details.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check82 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.